Transthyretin amyloidosis (ATTR amyloidosis) is a multisystemic, life-threatening disease resulting from the deposition of transthyretin (TTR) amyloid fibrils in the heart, peripheral nerves, and other tissues, leading mainly to polyneuropathy and/or cardiomyopathy [1]. The gene discussed is TTR; the disease is polyneuropathy.